glp 1 risk of pancreatitis GLP-1 Agonists and Dose-dependent pancreatitis risk associated with

Microdosing GLP-1 for Hashimoto's: explore the evidence, potential benefits, safety concerns, and NHS guidance on using GLP-1 receptor agonists for autoimmune thyroid disease and metabolic symptoms.

Patients taking glucagon-like peptide-1 (GLP-1) drugs like semaglutide for diabetes may have a lower risk of opioid drug overdose, according to a new study led

Lose weight with GLP-1 medications

Results A total of 19 studies were included in this systematic review

A fair look at Ro: program overview, medication approach, pricing, and the genetic variable the brand does not address

To help answer these and many others, I recently launched The GLP-1 Dietitian Hub, a growing community and newsletter dedicated to empowering dietitians with practical, up to date resources, relevant research, and a space to connect so we can navigate GLP-1 therapy with confidence